Avita Medical reported AUD47.78M in Assets for its fiscal semester ending in June of 2026.





Assets Change Date
Accuray USD 448.01M 8.81M Dec/2025
Celltrion KRW 779.18B 10.37B Jun/2026
Clinuvel Pharmaceuticals AUD 269.7M 2.05M Dec/2025
Cochlear AUD 2.79B 31.3M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.28B 62.98M Sep/2026
Divis Laboratories Ltd INR 219.64B 19.31B Sep/2026
Kangmei Pharma CNY 13.07B 239.31M Jun/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Nanosonics AUD 279.25M 6.77M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Organigram Holdings CAD 820.26M 298.95M Jun/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pacific Edge NZD 17.6M 17.06M Jun/2026
Pharma Mar EUR 408.4M 14.8M Sep/2026
Polynovo AUD 123.37M 4.04M Dec/2025
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Qiagen NV USD 5.89B 107.14M Jun/2026
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
ResMed USD 8.97B 181.66M Jun/2026
Sartorius EUR 9.67B 70.9M Sep/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Telix Pharmaceuticals AUD 1.36B 197.86M Jun/2026
Tilray USD 2.1B 15.95M Sep/2025
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 17.71B 799.05M Sep/2026